中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors

文献类型:期刊论文

作者Wang, Huiyuan2; Jiang, Yifan2; Peng, Huige2; Chen, Yingzhi2; Zhu, Peizhi1; Huang, Yongzhuo2
刊名ADVANCED DRUG DELIVERY REVIEWS
出版日期2015-01
卷号81页码:142-160
关键词MicroRNA Drug delivery Non-viral vector Synthetic vector Cancer therapy
ISSN号0169-409X
DOI10.1016/j.addr.2014.10.031
文献子类Review
英文摘要MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression. Because of significant changes in their expression in cancer, miRNAs are believed to be key factors in cancer genetics and to have potential as anticancer drugs. However, the delivery of miRNAs is limited by many barriers, such as low cellular uptake, immunogenicity, renal clearance, degradation by nucleases, elimination by phagocytic immune cells, poor endosomal release, and untoward side effects. Nonviral delivery systems have been developed to overcome these obstacles. In this review, we provide insights into the development of non-viral synthetic miRNA vectors and the promise of miRNA-based anticancer therapies, including therapeutic applications of miRNAs, challenges of vector design to overcome the delivery obstacles, and the development of miRNA delivery systems for cancer therapy. Additionally, we highlight some representative examples that give a glimpse into the current trends into the design and application of efficient synthetic systems for miRNA delivery. Overall, a better understanding of the rational design of miRNA delivery systems will promote their translation into effective clinical treatments. (C) 2014 Elsevier B.V. All rights reserved.
WOS关键词SMALL INTERFERING RNA ; MOLECULAR-WEIGHT POLYETHYLENIMINE ; NANOPARTICLE-MEDIATED DELIVERY ; SHORT BRANCH PEI ; GENE DELIVERY ; IN-VIVO ; LUNG-CANCER ; REPLACEMENT THERAPY ; TARGETED DELIVERY ; SYSTEMIC DELIVERY
资助项目National Basic Research Program of China (973 Program)[2014CB931902] ; National Basic Research Program of China (973 Program)[2013CB932503] ; NSFC, China[81172996] ; NSFC, China[81373357] ; NSFC, China[81422048] ; NSFC, China[81402883] ; Chinese Postdoctoral Science Foundation[2012M510097] ; Chinese Postdoctoral Science Foundation[2013T60478]
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000348621600012
出版者ELSEVIER SCIENCE BV
源URL[http://119.78.100.183/handle/2S10ELR8/276759]  
专题药物制剂研究中心
通讯作者Huang, Yongzhuo
作者单位1.Yangzhou Univ, Coll Chem & Chem Engn, Yangzhou 225009, Jiangsu, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China;
推荐引用方式
GB/T 7714
Wang, Huiyuan,Jiang, Yifan,Peng, Huige,et al. Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors[J]. ADVANCED DRUG DELIVERY REVIEWS,2015,81:142-160.
APA Wang, Huiyuan,Jiang, Yifan,Peng, Huige,Chen, Yingzhi,Zhu, Peizhi,&Huang, Yongzhuo.(2015).Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors.ADVANCED DRUG DELIVERY REVIEWS,81,142-160.
MLA Wang, Huiyuan,et al."Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors".ADVANCED DRUG DELIVERY REVIEWS 81(2015):142-160.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。